Shenwei Pharmaceutical (02877) rose by more than 5%, reaching a new high of HK$10.1 since July 2018. As of press release, it rose 5.44% to HK$10.08, with a turnover of HK$29.741,900.
The Zhitong Finance App learned that Shenwei Pharmaceutical (02877) rose by more than 5%, reaching a new high of HK$10.1 since July 2018. As of press release, it rose 5.44% to HK$10.08, with a turnover of HK$29.741,900.
According to the news, Shenwei Pharmaceutical recently announced that profit attributable to company owners for the year ending December 31, 2023 is expected to increase by about 30% to 36% over the same period last year, and the profit attributable to company owners in 2022 is about 723 million yuan. The expected increase in net profit is mainly due to a 14% increase in the Group's overall sales revenue compared to last year and a decrease of about 2 to 3 percentage points in the ratio of sales and distribution costs to turnover compared to last year.